India Ratings assigns Torrent Pharmaceuticals at IND AA+, outlook Stable
Torrent Pharmaceuticals (TORNTPHARM) said India Ratings has assigned its credit rating at IND AA+ with a stable outlook. The company is valued at about ₹1.79 lakh crore.
What happened
Torrent Pharmaceuticals (TORNTPHARM) told the exchanges on 7 October 2026 at 07:32 PM that India Ratings has assigned its credit rating at IND AA+ with a stable outlook.
From the filing: "The rating along with outlook is IND AA+/Positive; and • Affirmed and Assigned the credit rating for the existing and proposed Commercial paper of the Company respectively at IND A1+."
Company snapshot
Torrent Pharmaceuticals is a large-cap company in the Healthcare sector, with a market value of about ₹1.79 lakh crore.
The stock last traded at ₹4,716.2, against a 52-week range of ₹3,480.6–₹5,250 (10.2% below the high).
Before this filing the shares had moved −1.8% over the month and −1.9% over three months. Average daily turnover over the last 20 sessions was about ₹168 crore.
Promoters held 60.78% at the end of Q2 FY27, down 7.53% points from the previous quarter. Foreign institutions owned 17.97% and domestic institutions 12.87%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 3,178 | 548 | 16.19 |
| Q2 FY26 | 3,302 | 591 | 17.45 |
| Q3 FY26 | 3,303 | 635 | 18.77 |
| Q4 FY26 | 4,197 | 389 | 11.51 |
| Q1 FY27 | 4,921 | 566 | 14.87 |
What history shows
BCEIE has no earlier credit rating filing from this company on record since May 2026.
Across 28 similar disclosures by other Healthcare companies, shares moved +0.0% on average the next day and +1.6% over five days; 61% of them rose the next day.
Market-wide, 1,237 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Whether other agencies take a similar view on the company's credit.
- 23 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- TORNTPHARM Outlook for the Week
- Torrent Pharmaceuticals (TORNTPHARM) Share Price Falls 2.1% Today; Large Cap Stock Faces Valuation Check
- Torrent Pharmaceuticals (NSE:TORNTPHARM): Why Has the Trading Window Been Closed?
- Torrent Pharmaceuticals stock reports 54.6 percent sales growth
- Torrent Pharmaceuticals Share Price after Rs 100 decline
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.